ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat breast cancer in major trial
Disease control OngoingThis study tests a new drug, trastuzumab deruxtecan (T-DXd), against standard chemotherapy in 866 people with a common type of advanced breast cancer (HER2-low, hormone receptor-positive) that has stopped responding to hormone therapy. The goal is to see if T-DXd can delay cancer…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug combo aims to control advanced breast cancer after standard treatment fails
Disease control OngoingThis study tests a new medicine (PF-07220060) taken with fulvestrant against other standard treatments for people with advanced or metastatic HR+/HER2- breast cancer whose disease worsened after prior CDK4/6 inhibitor therapy. About 333 adults will be randomly assigned to receive…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 07, 2026 18:40 UTC